| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9016319 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2005 | 7 Pages |
Abstract
CAIs show a very promising therapeutic potential in the treatment of chronic TBI. There were no significant differences between the three drugs. Large-scale randomised double-blinded placebo-controlled studies are clearly needed.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Olli Tenovuo,